{"created":"2023-05-15T14:42:52.671649+00:00","id":58750,"links":{},"metadata":{"_buckets":{"deposit":"d9af7531-a834-4cd0-bdc2-44148ba37a82"},"_deposit":{"created_by":1,"id":"58750","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"58750"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00058750","sets":["11"]},"author_link":["586203","586201","586202","586200"],"item_10004_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2017-05","bibliographicIssueDateType":"Issued"},"bibliographic_titles":[{"bibliographic_title":"市民のためのがん治療の会　シリーズがん治療の今"}]}]},"item_10004_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"67Cuは１人の患者さんに、１種類の放射性医薬品を用いて診断と治療が行える、「個別化医療」へ向けた理想的なRIである。そのため、67Cu医薬品の実用化を目指して高品質の67Cuを大量に製造する研究開発が、30年余にわたり世界中で行われてきたが、その製造法は未だ確立せず、67Cu医薬品の研究開発が停滞する状況が続いている。私達は、加速器を利用した67Cuの新しい製造法を提案し、実験によりこの製造法による67Cuが上記要求を満たすことを明らかにした。更に大腸がんを移植したマウスにこの67Cuを投与した実験を行い、67Cuが腫瘍部に顕著に集積することを発見した。本稿では、67Cuに関する我々の最新の研究成果を研究開発の内容を交えながら紹介している。","subitem_description_type":"Abstract"}]},"item_10004_relation_17":{"attribute_name":"関連サイト","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"http://www.com-info.org/medical.php"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"http://www.com-info.org/medical.php","subitem_relation_type_select":"URI"}}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"永井, 泰樹"}],"nameIdentifiers":[{"nameIdentifier":"586200","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"川端, 方子"}],"nameIdentifiers":[{"nameIdentifier":"586201","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"永井 泰樹","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"586202","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"川端 方子","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"586203","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"がん診断と治療用放射性銅67医薬品の国産化に向けて","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"がん診断と治療用放射性銅67医薬品の国産化に向けて"}]},"item_type_id":"10004","owner":"1","path":["11"],"pubdate":{"attribute_name":"公開日","attribute_value":"2017-05-12"},"publish_date":"2017-05-12","publish_status":"0","recid":"58750","relation_version_is_last":true,"title":["がん診断と治療用放射性銅67医薬品の国産化に向けて"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T22:12:36.022421+00:00"}